FY2026 Earnings Forecast for Aemetis Issued By HC Wainwright

Aemetis, Inc (NASDAQ:AMTX – Free Report) – HC Wainwright upped their FY2026 earnings estimates for Aemetis in a research note issued to investors on Friday, November 6th. HC Wainwright analyst A. Dayal now anticipates that the specialty chemicals company will earn ($0.55) per share for the year, up from their previous forecast of ($0.88). The consensus estimate for Aemetis’ current full-year earnings is ($0.89) per share. HC Wainwright also issued estimates for Aemetis’ Q4 2026 earnings at ($0.16) EPS, FY2027 earnings at ($0.28) EPS, FY2028 earnings at $0.74 EPS and FY2029 earnings at $2.15 EPS.

Aemetis (NASDAQ:AMTX – Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The specialty chemicals company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.18. The business had revenue of $88.15 million during the quarter, compared to the consensus estimate of $74.20 million.

AMTX has been the topic of several other reports. Weiss Ratings restated a “sell (e+)” rating on shares of Aemetis in a research report on Thursday, October 15th. Wall Street Zen upgraded Aemetis from a “sell” rating to a “hold” rating in a report on Saturday, August 22nd. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $11.88.

View Our Latest Analysis on AMTX

Aemetis Stock Performance

Shares of Aemetis stock opened at $1.73 on Tuesday. The firm has a fifty day moving average of $1.66 and a two-hundred day moving average of $1.95. The stock has a market capitalization of $124.85 million, a price-to-earnings ratio of -3.09 and a beta of 1.87. Aemetis has a 52 week low of $1.11 and a 52 week high of $3.80.

Hedge Funds Weigh In On Aemetis

Institutional investors have recently modified their holdings of the business. Russell Investments Group Ltd. grew its position in shares of Aemetis by 458.6% in the 3rd quarter. Russell Investments Group Ltd. now owns 434,404 shares of the specialty chemicals company’s stock valued at $773,000 after purchasing an additional 356,636 shares during the period. Bank of America Corp DE increased its stake in Aemetis by 148.3% during the 1st quarter. Bank of America Corp DE now owns 101,486 shares of the specialty chemicals company’s stock worth $324,000 after purchasing an additional 60,611 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in Aemetis during the 2nd quarter worth approximately $283,000. Renaissance Technologies LLC acquired a new stake in Aemetis during the 1st quarter worth approximately $272,000. Finally, State of Wyoming bought a new position in Aemetis in the third quarter valued at approximately $226,000. Institutional investors own 27.02% of the company’s stock.

About Aemetis

(Get Free Report)

Aemetis, Inc is a renewable fuels and carbon-reduction company that develops and operates projects designed to produce lower-carbon alternatives to petroleum-based fuels and reduce greenhouse-gas emissions. Its activities include renewable natural gas, ethanol, renewable diesel, and other advanced fuel technologies.

The company’s California operations include dairy-based renewable natural gas projects that capture methane from dairy waste and convert it into pipeline-quality fuel. Aemetis also operates an ethanol production facility in Keyes, California, which produces ethanol and related co-products from agricultural feedstocks.

Read More

Earnings History and Estimates for Aemetis (NASDAQ:AMTX)

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.